The estimated Net Worth of Campbell Rogers is at least 22.7 千$ dollars as of 21 March 2016. Campbell Rogers owns over 8,474 units of InspireMD Inc stock worth over 22,713$ and over the last 11 years he sold NSPR stock worth over 0$. In addition, he makes 0$ as Independent Director at InspireMD Inc.
Sign up
Campbell Rogers NSPR stock SEC Form 4 insiders trading
Campbell has made over 1 trades of the InspireMD Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 8,474 units of NSPR stock worth 5,000$ on 21 March 2016.
The largest trade he's ever made was buying 8,474 units of InspireMD Inc stock on 21 March 2016 worth over 5,000$. On average, Campbell trades about 404 units every 0 days since 2013. As of 21 March 2016 he still owns at least 8,475 units of InspireMD Inc stock.
You can see the complete history of Campbell Rogers stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Campbell Rogers biography
Dr. Campbell Rogers, M.D. is Independent Director of the Company. He served as chief medical officer of Heart Flow, Inc., a cardiovascular diagnostics company, since March 2012. Prior to joining Heart Flow, Inc., he was the chief scientific officer and global head of research and development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices, from July 2006 to March 2012. Prior to that, he was associate professor of medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology and director of the cardiac catheterization and experimental cardiovascular interventional laboratories at Brigham and Women’s Hospital. He served as principal investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases and was the recipient of research grant awards from the National Institute of Health and the American Heart Association. He received his A.B. from Harvard College and his M.D. from Harvard Medical School. Dr. Rogers’ qualifications to serve on the board include his significant experience in cardiovascular devices, as well as his familiarity with the operations of medical device companies.
How old is Campbell Rogers?
Campbell Rogers is 55, he's been the Independent Director of InspireMD Inc since 2013. There are 9 older and no younger executives at InspireMD Inc. The oldest executive at InspireMD Inc is Dr. Sol J. Barer Ph.D., 74, who is the Special Advisor to the Board.
What's Campbell Rogers's mailing address?
Campbell's mailing address filed with the SEC is C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV, L3, 6744832.
Insiders trading at InspireMD Inc
Over the last 13 years, insiders at InspireMD Inc have traded over 1,684,082$ worth of InspireMD Inc stock and bought 3,887,125 units worth 5,293,286$ . The most active insiders traders include Sol J Barer、Eli Bar、Gary S Roubin. On average, InspireMD Inc executives and independent directors trade stock every 97 days with the average trade being worth of 319,459$. The most recent stock trade was executed by Gary S Roubin on 30 November 2023, trading 50,000 units of NSPR stock currently worth 126,500$.
What does InspireMD Inc do?
inspiremd, inc. is a company based out of 800 boylston street suite 16041, boston, massachusetts, united states.
What does InspireMD Inc's logo look like?
Complete history of Campbell Rogers stock trades at InspireMD Inc
InspireMD Inc executives and stock owners
InspireMD Inc executives and other stock owners filed with the SEC include:
-
Marvin L. Slosman,
Pres, CEO & Director -
Craig Shore,
CFO, Chief Admin. Officer, Sec. & Treasurer -
Craig Shore,
Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary -
Campbell Rogers,
Independent Director -
Michael Berman,
Independent Director -
Gary Roubin,
Director -
Thomas Kester,
Director -
Agustin Gago,
Executive Vice President, Chief Commercial Officer -
Isaac Blech,
Independent Vice Chairman of the Board -
Marvin Slosman,
Chief Executive Officer, Director -
Paul Stuka,
Chairman of the Board -
Dr. Sol J. Barer Ph.D.,
Special Advisor to the Board -
Amir Kohen,
VP of Fin. & International HR -
Andrea Tommasoli,
Sr. VP of Global Sales & Marketing -
Roei Samuri,
VP of Operations -
Sol J Barer,
Director -
James J Barry,
President and CEO -
James J Loughlin,
Director -
Alan Milinazzo,
President and CEO -
Eric L. Olson,
VP of Global Sales Operations -
Eli Bar,
CTO InspireMD Ltd. -
Asher Holzer,
Director -
Eyal Weinstein,
Director -
Kathryn Arnold,
Director -
Shane Thomas Gleason,
Chief Commercial Officer -
Patrick Verta,
EVP Clinical/Medical Affairs